Sage Rhino Capital LLC Astrazeneca PLC Transaction History

Sage Rhino Capital LLC

$419 Million
Q1 2025

A detailed history of Sage Rhino Capital LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Sage Rhino Capital LLC holds 12,259 shares of AZN stock, worth $856,291. This represents 0.22% of its overall portfolio holdings.

Number of Shares

12,259

Previous 11,864 3.33%

Holding current value

$856,291

Previous $777,000 15.96%

% of portfolio

0.22%

Previous 0.17%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	BUY	$65.37 - $77.96 $25,821 - $30,794	395 Added 3.33%	12,259 $901,000
Q4 2024 Feb 06, 2025	SELL	$63.2 - $79.58 $10,112 - $12,732	-160 Reduced 1.33%	11,864 $777,000
Q3 2024 Nov 01, 2024	BUY	$76.67 - $87.62 $11,423 - $13,055	149 Added 1.25%	12,024 $936,000
Q2 2024 Jul 30, 2024	BUY	$66.81 - $80.83 $16,502 - $19,965	247 Added 2.12%	11,875 $926,000
Q1 2024 Apr 26, 2024	BUY	$61.03 - $69.57 $15,013 - $17,114	246 Added 2.16%	11,628 $787,000
Q4 2023 Feb 05, 2024	SELL	$61.89 - $69.28 $8,293 - $9,283	-134 Reduced 1.16%	11,382 $766,000
Q3 2023 Oct 26, 2023	BUY	$64.85 - $71.7 $10,051 - $11,113	155 Added 1.36%	11,516 $779,000
Q2 2023 Jul 31, 2023	BUY	$69.91 - $75.81 $41,107 - $44,576	588 Added 5.46%	11,361 $813,000
Q1 2023 Apr 20, 2023	BUY	$63.15 - $71.6 $9,472 - $10,740	150 Added 1.41%	10,773 $747,000
Q4 2022 Jan 31, 2023	SELL	$54.21 - $70.44 $19,840 - $25,781	-366 Reduced 3.33%	10,623 $720,000
Q3 2022 Oct 24, 2022	SELL	$53.02 - $135.75 $17,655 - $45,204	-333 Reduced 2.94%	10,989 $603,000
Q2 2022 Jul 28, 2022	BUY	$59.26 - $71.14 $24,592 - $29,523	415 Added 3.8%	11,322 $748,000
Q1 2022 Apr 27, 2022	BUY	$55.72 - $67.12 $28,027 - $33,761	503 Added 4.83%	10,907 $724,000
Q4 2021 Feb 04, 2022	BUY	$54.02 - $63.83 $71,630 - $84,638	1,326 Added 14.61%	10,404 $606,000
Q3 2021 Oct 18, 2021	BUY	$55.56 - $60.79 $47,614 - $52,097	857 Added 10.42%	9,078 $545,000
Q2 2021 Jul 27, 2021	BUY	$48.42 - $60.18 $21,111 - $26,238	436 Added 5.6%	8,221 $492,000
Q1 2021 May 04, 2021	BUY	$47.16 - $54.44 $6,932 - $8,002	147 Added 1.92%	7,785 $387,000
Q4 2020 Feb 03, 2021	SELL	$48.52 - $58.02 $116,593 - $139,422	-2,403 Reduced 23.93%	7,638 $382,000
Q3 2020 Nov 05, 2020	BUY	$53.07 - $61.1 $10,083 - $11,609	190 Added 1.93%	10,041 $550,000
Q2 2020 Jul 30, 2020	BUY	$43.1 - $55.31 $8,921 - $11,449	207 Added 2.15%	9,851 $521,000
Q1 2020 Apr 29, 2020	BUY	$37.79 - $51.33 $159,020 - $215,996	4,208 Added 77.41%	9,644 $431,000
Q4 2019 Jan 31, 2020	BUY	$42.46 - $50.46 $4,330 - $5,146	102 Added 1.91%	5,436 $271,000
Q3 2019 Oct 25, 2019	BUY	$40.12 - $45.47 $5,295 - $6,002	132 Added 2.54%	5,334 $238,000
Q2 2019 Aug 20, 2019	BUY	$37.28 - $41.68 $193,930 - $216,819	5,202 New	5,202 $215,000

Others Institutions Holding AZN

# of Institutions

1,428

Shares Held

504M

Call Options Held

10M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $216B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.

Account

Sage Rhino Capital LLC Astrazeneca PLC Transaction History